NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Protembis GmbH

Protembis GmbH

Private
AachenHealthcare & Life Scienceshttps://protembis.com/

Last Round

Debt

Jul 30, 2024

Total Funding Raised

$64.22M

Company Overview

Protembis GmbH is a medical device company that develops the ProtEmbo® Cerebral Protection System, an intra-aortic filter device designed to protect the brain from embolic material during transcatheter aortic valve replacement (TAVR) procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

cerebral embolic protectionCEPtranscatheter aortic valve replacementTAVRembolic protection devicestroke preventioncardiovascular medical deviceinterventional cardiologyaortic arch filtermedtechstructural heartembolic debris capture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Protembis GmbH Comparables

Compare Protembis GmbH with similar companies based on industry and business-model similarity.

Protembis GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Emboline
94%
Transverse Medical
93%
AorticLab S.r.l.
93%

Protembis GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 30, 2024
Series BMar 26, 2024
Series AOct 26, 2018

Key People

Founding team and executive leadership

Conrad Rasmus

Co-CEO Co-Founder

Founding Team

Protembis GmbH Investors

Notable investors and investment history

Protembis GmbH investors
InvestorRounds
XGEN VentureSeries B
Tech Vision FondsSeries B
European Investment Bank GroupDebt
Segulah Medical AccelerationSeries B
CoparionSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2024

    $22M round led by European Investment Bank Group

  • Mar 26, 2024

    $33M round led by Segulah Medical Acceleration.

Protembis GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Protembis GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Protembis GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersAachen
Employee Range22
Year Founded2013
Last FundingJul 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.